11/8/2012Review of Chinese Hospital Markets for Antiplatelet Drugs and Human Al...

11/8/2012SFDA Tests Decentralization of Certain Drug Evaluation Responsibilitie...

11/8/2012Shenzhen Salibris to Acquire Rights of Allisartan from Shanghai Allist

11/8/2012Health Minister Meets Baxter Chairman and CEO

11/7/2012Paper on Private Hospitals and Survey Findings on Physician Kickbacks ...

11/7/2012Leveraging U.S. Resources and Chinese Partnership for Drug Development...

11/7/2012SFDA Issues Application Rules for Drug and Medical Device Administrati...

11/7/2012Recent Official and Executive Moves

11/6/2012Upcoming Event: Senior Pharma Executive Forum - China Meets Europe

11/6/2012Upcoming Event: Driving Behavior and Accountability - How Successful E...

11/6/2012Upcoming Event: Adaptable Thinking in Corporate Development

11/6/2012India Revokes Roche Patent for Hepatitis Drug Pegasys

11/6/2012Updated: Trade Growth of Medicines and Health Products Slows in First ...

11/6/2012Shanghai Initiates Trial to Separate Drug Sales from Medical Services

11/5/2012China Diabetes Triples Creating $3.2 Billion Drug Market (External)

11/5/2012China to Issue Stem Cell Research Regulations Soon

11/5/2012CTL and Zhongyuan Union Enter Agreement for Stem Cell Anti-aging Resea...

11/5/2012Pharma Voice: China's Pharma Star Shines Bright (External)

11/2/2012Guangdong Initiates County Level Public Hospital Reform Trials

11/2/2012CAS and Sichuan Establishes Translational Medicine Research Hospital

11/1/2012Anhui Introduces Essential Drug List for County Level Hospitals

11/1/2012MOH Highlights Healthcare Cost Containment in 2012

11/1/2012Chi-Med Initiates Phase I Trial of Novel Oncology Drug

11/1/2012CDE Launches Drug Clinical Trial Public Platform and English Webpage

11/1/2012Bayer Expands Consumer Healthcare Business with Latest Schiff Acquisit...

10/31/2012Pharma Industry Performance Improves in the Third Quarter

10/31/2012New Study: Global High Potency API Market to Reach US$17.5B in 2018

10/31/2012Charles River Acquires 75% of Chinese CRO Vital River

10/31/2012SFDA Clears Sihuan's First-to-Market Generic Roxatidine in China

10/31/2012Fosun Phamra Raises US$510M from IPO in Hong Kong at Bottom of Range

Page:526/775 Total number of articles:23243: [First][<<] [524] [525] [526] [527] [528] [>>] [End]